Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lexicon Pharmaceuticals (LXRX) EPS (Basic) (2024 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed EPS (Basic) for 4 consecutive years, with -$0.04 as the latest value for Q3 2025.

  • Quarterly EPS (Basic) rose 77.78% to -$0.04 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$0.03 through Dec 2025, up 91.43% year-over-year, with the annual reading at -$0.34 for FY2011, 0.0% changed from the prior year.
  • EPS (Basic) for Q3 2025 was -$0.04 at Lexicon Pharmaceuticals, down from $0.01 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.01 in Q2 2025, with the low at -$0.18 in Q3 2024.